Sort
48,018 grants matching “immunotherapy”
Core B: Molecular Pathology and Bioinformatics Core
$689,119Michael F. Berger · Sloan-Kettering Inst Can Research · P01 · FY2024 · CA
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
$689,091Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2022 · CA
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
$689,091Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2023 · CA
Identifying and modulating pathologic T cells that govern oral mucosal immune related adverse events from immune checkpoint blockade
$689,062Rajan P. Kulkarni · Oregon Health & Science University · R01 · FY2025 · DE
Interrogating Mechanisms of Anti-tumor Immunity in Human Subjects and Murine Models of IDH-Mutant Glioma Treated with All-Trans Retinoic Acid and PD-1 Inhibition
$689,044Nduka Mgbechinyere Amankulor · University Of Pennsylvania · R37 · FY2024 · CA
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$689,042Harvinder Singh Gill · Texas Tech University · R01 · FY2021 · AI
Integration of epidemiology, pathology, immunology and outcomes in colorectal cancer
$688,965Stephen B Gruber · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$688,917Kathryn Miller-Jensen · Yale University · U01 · FY2021 · CA
Defining the role of cytomegalovirus in glioblastoma therapies
$688,910Sean Edward Lawler · Brown University · R01 · FY2022 · CA
Clinical trials employing cancer vaccine combination therapies
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Immunologic Correlates of Immunization for Cancer
$688,813University Of Washington · U54 · FY2001 · CA
Engineered âmuco-trappingâ antibodies for inhaled therapy of parainfluenza and human metapneumovirus infections
$688,413Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Engineered âmuco-trappingâ antibodies for inhaled therapy of parainfluenza and human metapneumovirus infections
$688,330Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
A physical sciences approach to investigate the role of exosomes in metastatic progression
$688,299Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2021 · CA
PERSONALIZED T-CELL IMMUNOTHERAPY FOR RENAL CELL CARCINOMA
$688,237Fred Hutchinson Cancer Research Center · · FY2019 · Defense Health Agency
Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation
$688,080Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
$688,043Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2018 · CA
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$688,018Benjamin G. Neel · New York University School Of Medicine · R01 · FY2022 · CA
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$688,018Benjamin G. Neel · New York University School Of Medicine · R01 · FY2023 · CA
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
$688,005Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
$687,979Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Neural response to inflammatory challenge in major depressive disorder
$687,903Jonathan Savitz · Laureate Institute For Brain Research · R01 · FY2025 · MH
Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment
$687,824Lan Zhou · Methodist Hospital Research Institute · R01 · FY2024 · CA
Neural response to inflammatory challenge in major depressive disorder
$687,812Jonathan Savitz · Laureate Institute For Brain Research · R01 · FY2022 · MH